{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1","upperLimit":"4","value":"2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"62"}],"units":"Participants"}],"dispersionType":"Full Range","groups":[{"description":"Everolimus 10 mg PO daily + Letrozole 2.5 mg PO daily + Metformin 500 mg PO twice daily on a 4 week schedule","id":"OG000","title":"Rad-Let-Met"}],"paramType":"MEDIAN","populationDescription":"There were 9 patients who had mutational analysis on their primary tumor in addition to the research biopsy performed as part of the study.","reportingStatus":"POSTED","timeFrame":"93 months","title":"Number of Mutations Detected in Women With Endometrial Cancer","type":"SECONDARY","unitOfMeasure":"mutations detected"}